282 related articles for article (PubMed ID: 33144449)
1. Capecitabine Plus Bevacizumab for Cardiac Metastasis of Sigmoid Colon Cancer: Case Report and Literature Review.
Hiroi S; Miguchi M; Ikeda S; Nakahara H; Shinozaki K; Nishisaka T; Egi H; Itamoto T
In Vivo; 2020; 34(6):3413-3419. PubMed ID: 33144449
[TBL] [Abstract][Full Text] [Related]
2. [Recurrent rectal cancer with multiple liver and lung metastases treated effectively with oxaliplatin and capecitabine plus bevacizumab chemotherapy-a case report].
Yabe N; Murai S; Shimizu H; Kitasato K; Yoshikawa T; Oto I; Nakadai J; Hasegawa H; Kitagawa Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1834-6. PubMed ID: 24393938
[TBL] [Abstract][Full Text] [Related]
3. [A Case of Recurrent Sigmoid Colon Cancer with Peritoneal Metastasis and Liver Metastasis Successfully Treated with Capecitabine plus Bevacizumab].
Nakano M; Mokutani Y; Hirose H; Yoshioka S; Mizuno M; Fukada A; Nagano S; Kidogami S; Kishimoto T; Hashimoto Y; Kawada J; Fujita J; Tamura S; Sasaki Y
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1917-1919. PubMed ID: 36733043
[TBL] [Abstract][Full Text] [Related]
4. [A Case of Sigmoid Colon Cancer with Synchronous Liver Metastasis, Treated with Laparoscopic Liver Resection after SOX plus BV Chemotherapy].
Shimizu Y; Ando K; Oda K; Kubosawa H; Miyazaki M
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2163-5. PubMed ID: 26805298
[TBL] [Abstract][Full Text] [Related]
5. [Long-Term Disease Control with Capecitabine plus Bevacizumab Therapy for an Elderly Patient with Unresectable Colon Cancer-A Case Report].
Takenoya T; Yabe N; Kamoya M; Furuichi S; Morishige S; Tamura E; Yajima K; Iwama N; Oto I; Yoshikawa T; Osumi K; Murai S
Gan To Kagaku Ryoho; 2020 Dec; 47(13):1798-1800. PubMed ID: 33468833
[TBL] [Abstract][Full Text] [Related]
6. [Brain Metastasis Following Conversion Surgery for Sigmoid Colon Cancer-A Case Report].
Takenoya T; Murai S; Ando H; Nakayama F; Asada Y; Oto I; Yoshikawa T; Nakamura T; Yabe N; Osumi K; Kameyama N
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1522-1524. PubMed ID: 38303328
[TBL] [Abstract][Full Text] [Related]
7. Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer.
Boisen MK; Johansen JS; Dehlendorff C; Larsen JS; Østerlind K; Hansen J; Nielsen SE; Pfeiffer P; Tarpgaard LS; Holländer NH; Keldsen N; Hansen TF; Jensen BB; Jensen BV
Ann Oncol; 2013 Oct; 24(10):2554-2559. PubMed ID: 23864097
[TBL] [Abstract][Full Text] [Related]
8. [A case of recurrent rectal cancer successfully treated for a long period with capecitabine plus oxaliplatin and bevacizumab therapy].
Iwata N; Ishikawa T; Takahashi H; Baba H; Masuda D; Okazaki S; Matsuyama T; Ishiguro M; Kobayashi H; Iida S; Uetake H; Sugihara K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2008-10. PubMed ID: 24393995
[TBL] [Abstract][Full Text] [Related]
9. Right or Left Primary Site of Colorectal Cancer: Outcomes From the Molecular Analysis of the AGITG MAX Trial.
Tapia Rico G; Price T; Tebbutt N; Hardingham J; Lee C; Buizen L; Wilson K; Gebski V; Townsend A
Clin Colorectal Cancer; 2019 Jun; 18(2):141-148. PubMed ID: 30713134
[TBL] [Abstract][Full Text] [Related]
10. Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) versus combination CapeOX/mFOLFOX6-Bmab in advanced colorectal cancer: the C-cubed (C3) study.
Nagasaka T; Mishima H; Sawaki A; Shimokawa M; Inukai M; Shinozaki K; Tanioka H; Nasu J; Nishina T; Hazama S; Okajima M; Yamaguchi Y
BMJ Open; 2016 Jun; 6(6):e011454. PubMed ID: 27256093
[TBL] [Abstract][Full Text] [Related]
11. [Complete resection of liver metastases of colorectal cancer after high efficacy bevacizumab, S-1, and CPT -11 combination chemotherapy].
Imai H; Sawada K; Sato A; Nishi K; Sasaki T; Takahashi T; Ohori H
Gan To Kagaku Ryoho; 2015 Jan; 42(1):101-4. PubMed ID: 25596689
[TBL] [Abstract][Full Text] [Related]
12. A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection.
Wong R; Cunningham D; Barbachano Y; Saffery C; Valle J; Hickish T; Mudan S; Brown G; Khan A; Wotherspoon A; Strimpakos AS; Thomas J; Compton S; Chua YJ; Chau I
Ann Oncol; 2011 Sep; 22(9):2042-2048. PubMed ID: 21285134
[TBL] [Abstract][Full Text] [Related]
13. Randomized Phase II Trial of CapOX plus Bevacizumab and CapIRI plus Bevacizumab as First-Line Treatment for Japanese Patients with Metastatic Colorectal Cancer (CCOG-1201 Study).
Nakayama G; Mitsuma A; Sunagawa Y; Ishigure K; Yokoyama H; Matsui T; Nakayama H; Nakata K; Ishiyama A; Asada T; Umeda S; Ezaka K; Hattori N; Takami H; Kobayashi D; Tanaka C; Kanda M; Yamada S; Koike M; Fujiwara M; Fujii T; Murotani K; Ando Y; Kodera Y
Oncologist; 2018 Aug; 23(8):919-927. PubMed ID: 30049885
[TBL] [Abstract][Full Text] [Related]
14. Phase I/II trial of capecitabine, oxaliplatin, and irinotecan in combination with bevacizumab in first line treatment of metastatic colorectal cancer.
Bazarbashi S; Aljubran A; Alzahrani A; Mohieldin A; Soudy H; Shoukri M
Cancer Med; 2015 Oct; 4(10):1505-13. PubMed ID: 26207614
[TBL] [Abstract][Full Text] [Related]
15. [A Case of Heterochronic Ovarian Metastasis from Sigmoid Colon Cancer after Sigmoidectomy Treated with CapeOX That Included Bevacizumab].
Ono R; Ise N; Yoshioka H; Iwasaki W; Sato K; Niwa M
Gan To Kagaku Ryoho; 2017 Jan; 44(1):83-85. PubMed ID: 28174387
[TBL] [Abstract][Full Text] [Related]
16. [A Super-Elderly Patient with Recurrent Colon Cancer with Metastasis Effectively Treated with Capecitabine plus Bevacizumab Chemotherapy-A Case Report].
Matsui S; Kajiyama D; Kawaguchi M; Ohira K; Amagasa H; Noguchi T; Sugita H; Ganno H; Imai K; Ami K; Fukuda A; Ando M
Gan To Kagaku Ryoho; 2018 Dec; 45(13):1943-1945. PubMed ID: 30692405
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients.
Ozcelik M; Odabas H; Ercelep O; Yuksel S; Mert AG; Aydin D; Surmeli H; Isik D; Isik S; Oyman A; Oven Ustaalioglu BB; Aliustaoglu M; Gumus M
Clin Transl Oncol; 2016 Jun; 18(6):617-24. PubMed ID: 26459249
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of capecitabine plus bevacizumab versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer from Chinese societal perspective.
Zhang PF; Wen F; Zhou J; Huang JX; Zhou KX; Wu QJ; Wang XY; Zhang MX; Liao WT; Li Q
Clin Transl Oncol; 2020 Jan; 22(1):103-110. PubMed ID: 31062173
[TBL] [Abstract][Full Text] [Related]
19. [Two Cases of Stage Ⅳ Colorectal Cancer with Long-Term Survival following Single-Agent Chemotherapy with Capecitabine-A Case Reports].
Suda K; Chiku T; Fukuyama M; Shinoda K; Hashiba H; Sano W; Ando K
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1882-1884. PubMed ID: 36733031
[TBL] [Abstract][Full Text] [Related]
20. Perioperative chemotherapy with or without bevacizumab in patients with metastatic colorectal cancer undergoing liver resection.
Constantinidou A; Cunningham D; Shurmahi F; Asghar U; Barbachano Y; Khan A; Mudan S; Rao S; Chau I
Clin Colorectal Cancer; 2013 Mar; 12(1):15-22. PubMed ID: 23021126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
